Compare GIL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIL | TECH |
|---|---|---|
| Founded | 1946 | 1976 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 10.2B |
| IPO Year | 1999 | 1995 |
| Metric | GIL | TECH |
|---|---|---|
| Price | $58.50 | $50.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | ★ $78.00 | $73.09 |
| AVG Volume (30 Days) | 1.5M | ★ 2.2M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.58% | 0.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $1,219,635,000.00 |
| Revenue This Year | $76.47 | $2.49 |
| Revenue Next Year | $4.88 | $6.40 |
| P/E Ratio | ★ $23.11 | $104.31 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $39.28 | $46.02 |
| 52 Week High | $73.70 | $72.16 |
| Indicator | GIL | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 24.38 | 35.09 |
| Support Level | $54.03 | $48.93 |
| Resistance Level | $62.40 | $54.08 |
| Average True Range (ATR) | 1.81 | 2.39 |
| MACD | -0.94 | -0.33 |
| Stochastic Oscillator | 3.12 | 24.21 |
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. It is a leader in blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels, a business that has been greatly enhanced by the Hanesbrands acquisition. Gildan's brands include Hanes, Bali, Maidenform, Playtex, Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates 90% of its sales in the US in 2025.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.